News
Trontinemab's Phase Ib/IIa Brainshuttle AD study continues to show rapid and robust clearance of amyloid plaques, with 91% becoming amyloid PET negative and ARIA-E remaining Design of the Phase III TR ...
Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with 91% ...
The Android Ecosystem Android has evolved from a simple mobile operating system to a vast ecosystem that powers billions of devices worldwide. As the most widely used mobile OS globally, Android’s ...
Gaming smartphone market pioneer Redmagic has officially launched its summer sale. The firm is giving fans the opportunity to ...
The Nothing Phone 3 fumbles little, proving a solid device all around. But it just falls short of its main competitors time ...
Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU
EMA’s CHMP issued an opinion not to recommend Elevidys™ (delandistrogene moxeparvovec) for the treatment of ambulatory ...
The Samsung Galaxy Z Fold 7 is available July 25, starting at $1,999. That entry price will get you a Fold 7 with 256GB of ...
For reference, 'fast charging' a phone requires 15 W or higher, which Qi2 currently hits, but only just. Most fast charging devices aim for 18 W, which the new standard will hit comfortably.
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid ...
Approval based on INAVO120 data showing the Itovebi™ (inavolisib)-based regimen more than doubled progression-free survival ...
Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will replace the non-voting equity securities (Genussscheine). Reduction of the nominal value of the bearer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results